This compound is a sulfonylurea derivative investigated as a pharmaceutical intermediate. It features an aromatic amide structure with ether and halogen substituents.
콘텐츠 범위: 이 페이지의 정보는 화학물질 식별 및 산업 공급·연구개발·제조 맥락을 대상으로 합니다. 치료 효능 주장, 의료 조언 또는 의약품 사용 지침에 해당하지 않습니다.
이 화합물을 구매하거나 공급하시겠습니까?
재고를 등록하거나 구매 요청을 게시하세요
CAS 16673-34-0
O-((Guanin-9-yl)methyl) acyclovir
Pharmaceutical intermediate
Glycinamide hydrochloride
pharmaceutical intermediate for peptide synthesis
Fmoc-N-(2,4-dimethoxybenzyl)-Gly-OH
Fmoc-protected amino acid for peptide synthesis
N-Fmoc-N-(2,4,6-trimethoxybenzyl)glycine
Pharmaceutical intermediate for peptide synthesis
Bezafibrate EP Impurity C
Pharmaceutical reference standard
Bezafibrate
antihyperlipoproteinemic active pharmaceutical ingredient
Alpha-(Benzoylamino)-4-hydroxy-N,N-dipropylbenzenepropanamide
Pharmaceutical intermediate for research
N--[4-(1-Methylethyl)benzoyl]-D-phenylalanine
Pharmaceutical intermediate for nateglinide
5-chloro-2-methoxy-N-[2-(4-sulfamoylphenyl)ethyl]benzamide
KVWWTCSJLGHLRM-UHFFFAOYSA-N
COC1=C(C=C(C=C1)Cl)C(=O)NCCC2=CC=C(C=C2)S(=O)(=O)N